FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Approves CoreValve IDE

[ Price : $8.95]

FDA conditionally approves an IDE and clinical trial protocol for Medtronics CoreValve System for aortic valve replacement.

FDA Approves Mylan's Generic Hyzaar and Cozaar Tablets

[ Price : $8.95]

FDA approves a Mylan ANDA for generic copies of Merck's antihypertensives Hyzaar and Cozaar.

What is Needed to Improve FDA? Professors Feud

[ Price : $8.95]

Harvard professors Daniel Carpenter and Marcia Angell feud over what has caused FDA to lose public trust and effectiveness and wha...

Botox Approved for Chronic Migraine

[ Price : $8.95]

FDA approves Allergans Botox injection to prevent headaches in adult patient with chronic migraine.

Class 1 Recall for Alaris Infusion Pump

[ Price : $8.95]

FDA classifies as Class 1 a recent recall involving CareFusion's Alaris PC Unit Model 8015 infusion pump.

OMB OKs Info on Product Jurisdiction

[ Price : $8.95]

Federal Register Notice: The Office of Management and Budget approves a collection of information on product jurisdiction for revi...

Lousiana Jury Orders $257.7 Million Risperdal Payment

[ Price : $8.95]

A Louisiana jury orders Johnson & Johnson to pay $257.7 million to the state for misleading doctors and defrauding the Medicaid pr...

Excelsior Prefilled Syringe Recall is Class 1

[ Price : $8.95]

FDA says an Excelsior Medical recall of prefilled saline syringes is a Class 1 recall.

FDA Approves Acthar sNDA

[ Price : $8.95]

FDA approves a Questcor Acthar sNDA for treating infantile spasms.

CDER Sending More Cases for Criminal Investigation

[ Price : $8.95]

CDER officials say they are increasing their interactions with FDA's Office of Criminal Investigations on enforcement matters.